Hemab Therapeutics Holdings, Inc. Common Stock

COAG

COAGHemab Therapeutics Holdings, Inc. Common Stock US flag

NASDAQ Global Market

39.51

USD

+1.48

- -

79.37MMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	50	70
+ Selling, General & Admin	9	10
+ Research & Development	41	60
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-50	-70
- Non-Operating (Income) Loss	-2	-6
+ Interest Expense, Net	-4	-2
+ Interest Expense	- -	- -
- Interest Income	4	2
+ Other Non-Op (Income) Loss	2	-4
Pretax Income	-49	-64
- Income Tax Expense (Benefit)	- -	- -
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-49	-64
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-49	-64
- Minority Interest	- -	- -
Net Income, GAAP	-49	-64
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-49	-64
EBIT	-50	-70
EBITDA	-50	-70
EBITDA Margin (%)	- -	- -
EBITA	-50	-70
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	- -	- -
Basic Weighted Avg Shares	27	27
Basic EPS, GAAP	-1.77	-2.33
Basic EPS from Cont Ops	-1.77	-2.33
Diluted Weighted Avg Shares	27	27
Diluted EPS, GAAP	-1.77	-2.33
Diluted EPS from Cont Ops	-1.77	-2.33

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	93	193
+ Cash, Cash Equivalents & STI	88	185
+ Cash & Cash Equivalents	74	88
+ ST Investments	14	98
+ Accounts & Notes Receiv	2	3
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	2	3
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	3	4
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	3	2
+ Property, Plant & Equip, Net	3	2
+ Property, Plant & Equip	3	2
- Accumulated Depreciation	- -	1
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	- -	1
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	- -	1
Total Assets	96	195
+ Payables & Accruals	4	7
+ Accounts Payable	3	6
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	1	1
+ ST Debt	1	1
+ ST Borrowings	- -	- -
+ ST Finance Leases	1	1
+ Other ST Liabilities	2	3
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	2	3
Total Current Liabilities	7	11
+ LT Debt	1	1
+ LT Borrowings	- -	- -
+ LT Finance Leases	1	1
+ Other LT Liabilities	204	360
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	204	360
Total Noncurrent Liabilities	205	361
Total Liabilities	212	371
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	3	5
+ Common Stock	- -	- -
+ Additional Paid in Capital	3	5
- Treasury Stock	- -	- -
+ Retained Earnings	-118	-182
+ Other Equity	- -	- -
Equity Before Minority Interest	-115	-177
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-115	-177
Total Liabilities & Equity	96	195
Shares Outstanding	44	44
Number of Employees	- -	- -
Capital Leases - Total	2	1
Net Debt	-74	-88
Net Debt to Equity	64.55	49.81
Tangible Common Equity Ratio	-119.73	-90.68
Current Ratio	13.95	18.03
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-49	-64
+ Depreciation & Amortization	- -	- -
+ Non-Cash Items	1	1
+ Stock-Based Compensation	2	2
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	- -	-1
+ Chg in Non-Cash Work Cap	1	1
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-2
+ Inc (Dec) in Accts Payable	2	4
+ Inc (Dec) in Other	- -	-1
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-46	-61
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	- -	- -
+ Acq of Fixed Prod Assets	- -	- -
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	62	-81
+ Dec in LT Investment	115	171
+ Inc in LT Investment	-53	-252
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	62	-81
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	- -	156
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	- -	156
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	16	13
EBITDA	-50	-70
EBITDA Margin (%)	- -	- -
Free Cash Flow	-46	-61
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-62
Free Cash Flow per Basic Share	-1.67	-2.24
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	0.94	0.96
Capital Expenditures	- -	- -